Climb Bio
Wellesley, MA
Associate Director/Medical Director, Clinical Development Climb Bio is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. Our product candidates include budoprutug, an anti-CD19 monoclonal antibody that presents us with an exciting opportunity given its broad potential applicability across a number of B-cell mediated diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy and CLYM116, an anti-APRIL monoclonal antibody in development for IgA nephropathy. At Climb Bio, our team has a knack for seeing what no one else seesand a drive to achieve results no one expects. We believe that our combined strength conquers any summit, and our core values Build Trust, Decide & Commit, Accelerate Impact, and Mark the Moment guide how we work, collaborate and innovate. They reflect our commitment to patients, each other, and the pursuit of transformative science. Reporting the Head of...